Company Overview and News

As Toys R Us Fails, the Retail Real Estate Glut Is Getting Worse - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Simon's Yield Above 5%: Safe Income Or Value Trap?

2018-04-15 seekingalpha
This article reviews the business, the negative market narratives (i.e. rising interest rates, increasing online shopping), the financial realities, Simon's valuation, and the M&A environment.
Upvote Downvote

Brookfield Property Partners Is A Buy On GGP Weakness

2018-04-08 seekingalpha
Shares currently have a better yield than outright purchases of commercial real estate without the hassle.
Upvote Downvote

Mall REITs: Bond Proxies Trading At Depressed Valuations

2018-04-05 seekingalpha
The Bloomberg Regional Mall Index, a market-cap weighted index of eight regional mall REITs, is trading near its six-year low.
Upvote Downvote

BPY / Brookfield Property Partners L.P. FORM 6-K (Current Report of Foreign Issuer)

Upvote Downvote

Brookfield Property Partners to Hold Conference Call  & Webcast of First Quarter 2018 Financial Results Friday, May 4, 2018 at 11:00 AM (ET)

2018-04-04 globenewswire
BROOKFIELD NEWS, April 04, 2018 (GLOBE NEWSWIRE) -- Brookfield Property Partners L.P. (NASDAQ:BPY) (TSX:BPY.UN) announced today that its first quarter 2018 financial results will be released before the market open on Friday, May 4, 2018. Analysts, investors and other interested parties are invited to participate in the company’s live conference call reviewing the results on Friday, May 4 at 11:00 AM (ET).
Upvote Downvote

PRESS DIGEST- Canada- April 4

2018-04-04 reuters
April 4 (Reuters) - The following are the top stories from select Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote Downvote

U.K. Retail Sector Shows Bright Spots as M&A Intrigue Intensifies - WSJ

2018-04-04 wsj
Bad news continued to mount in the U.S. retail real-estate industry last week as GGP Inc. accepted Brookfield Property Partners LP’s low-ball offer and new statistics showed vacancies in the regional mall sector hitting a six-year high.
Upvote Downvote

8 Stocks That Surprised Investors in Q1

2018-04-02 investorplace
The first quarter was an eventful one for U.S. equity markets. The quarter — and the year — started off well. A rally that had started in November 2016 U.S. continued through the end of January. The S&P 500 was at an all-time high — and the tech-heavy Nasdaq Composite was performing even better.
Upvote Downvote

Mall Vacancies Reach Six-Year High as Retail Slump Batters Local Economies - WSJ

2018-04-02 wsj
Empty space in regional shopping malls reached a six-year high in the first quarter, adding further stress to regions being hit by a retail earthquake that is shaking up the job market across the U.S.
Upvote Downvote

Brookfield Is Offering Fair Value For General Growth Properties

2018-03-31 seekingalpha
Brookfield Property Partners (BPY) has decided it wants to chase General Growth Properties (GGP). The offer though was raised very slightly from $23 to $23.50.
Upvote Downvote

Looking At Dividend Stocks For 2018

2018-03-31 seekingalpha
REITs are out of favor from the market, some of them are trading at excellent bargains.
Upvote Downvote

Eversendai branches out with O&G fabrication facility

EVERSENDAI Corp Bhd is banking on its recognition from Saudi Aramco to boost its order book in the oil and gas (O&G) sector.
Upvote Downvote

BPY / Brookfield Property Partners L.P. FORM 6-K (Current Report of Foreign Issuer)

Upvote Downvote

GGP: Let The Bidding War For This Mall REIT Begin

2018-03-29 seekingalpha
Brookfield Property Partners (BPY) came to an agreement with GGP (GGP) on terms to acquire the remaining 66% of GGP that they do not already own. This dramatically undervalues the true value of GGP’s shares and has caused many to question if “A malls” are really the value everybody makes them out to be. This does not impact the thesis behind Simon Property Group (SPG) - this deal at least proves that there are buyers for these fortress properties.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: G16249107